Skip Nav Destination
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myélome (IFM)
Issue Archive
January 7 2010
Table of Contents
INSIDE BLOOD
BLOOD WORK
PLENARY PAPERS
REVIEW ARTICLES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myélome (IFM)
Clinical Trials & Observations
Murielle Roussel,Philippe Moreau,Anne Huynh,Jean-Yves Mary,Clotaire Danho,Denis Caillot,Cyrille Hulin,Christophe Fruchart,Gérald Marit,Brigitte Pégourié,Pascal Lenain,Carla Araujo,Brigitte Kolb,Edouard Randriamalala,Bruno Royer,Anne-Marie Stoppa,Mammoun Dib,Véronique Dorvaux,Laurent Garderet,Claire Mathiot,Hervé Avet-Loiseau,Jean-Luc Harousseau,Michel Attal,for the Intergroupe Francophone du Myélome (IFM)
HEMATOPOIESIS AND STEM CELLS
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia
Nathalie Droin,Arnaud Jacquel,Jean-Baptiste Hendra,Cindy Racoeur,Caroline Truntzer,Delphine Pecqueur,Naïma Benikhlef,Marion Ciudad,Leslie Guery,Valérie Jooste,Erick Dufour,Pierre Fenaux,Bruno Quesnel,Olivier Kosmider,Michaëla Fontenay,Patrick Ducoroy,Eric Solary
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
Anticoagulant and antithrombotic properties of platelet protease nexin-1
Yacine Boulaftali,Frédéric Adam,Laurence Venisse,Véronique Ollivier,Benjamin Richard,Sabrina Taieb,Denis Monard,Rémi Favier,Marie-Christine Alessi,Marijke Bryckaert,Véronique Arocas,Martine Jandrot-Perrus,Marie-Christine Bouton
TRANSPLANTATION
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting
Luis I. Sánchez-Abarca,Silvia Gutierrez-Cosio,Carlos Santamaría,Teresa Caballero-Velazquez,Belen Blanco,Carmen Herrero-Sánchez,Juan L. García,Soraya Carrancio,Pilar Hernández-Campo,Francisco J. González,Teresa Flores,Laura Ciudad,Esteban Ballestar,Consuelo del Cañizo,Jesus F. San Miguel,Jose A. Pérez-Simon
Soluble lymphotoxin is an important effector molecule in GVHD and GVL
Kate A. Markey,Angela C. Burman,Tatjana Banovic,Rachel D. Kuns,Neil C. Raffelt,Vanessa Rowe,Stuart D. Olver,Alistair L. J. Don,Edward S. Morris,Allison R. Pettit,Yana A. Wilson,Renee J. Robb,Louise M. Randall,Heinrich Korner,Christian R. Engwerda,Andrew D. Clouston,Kelli P. A. MacDonald,Geoffrey R. Hill
VASCULAR BIOLOGY
A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo
Keguo Li,Yannick Blum,Anjali Verma,Zhong Liu,Kallal Pramanik,Noah R. Leigh,Chang Z. Chun,Ganesh V. Samant,Baofeng Zhao,Maija K. Garnaas,Mark A. Horswill,Stephen A. Stanhope,Paula E. North,Robert Q. Miao,George A. Wilkinson,Markus Affolter,Ramani Ramchandran
CORRESPONDENCE
ERRATUM
-
Cover Image
Cover Image
The cover depicts a characteristic leukemic cell from a newly diagnosed patient with hairy cell leukemia. Dr Gerard Lozanski provided this microphotograph of the leukemic cell in a Wright-Giemsa–stain smear of the peripheral blood. See the related article by Grever on page 21.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals